ArticleScience translational medicine2022

CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression.

Meiling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.